Experimental research

Safety and feasibility of percutaneous delivery of a novel circulatory assist device (CircuLite® SYNERGY®) in the swine model

EuroIntervention 2013;9:259-268. DOI: 10.4244/EIJV9I2A42

Geng-Hua Yi
Geng-Hua Yi1, MD; Yanping Cheng1, MD; Michael S. Aboodi1, BS; Robert Farnan2, BSME; Saibal Kar3, MD; Daniel Burkhoff2, MD, PhD; Gail Farnan2, RN; Juan F. Granada1*, MD
1. Skirball Center for Cardiovascular Research, Cardiovascular Research Foundation, Orangeburg, NY, USA; 2. CircuLite, Inc., Teaneck, NJ, USA; 3. Cedars Sinai Medical Center, Los Angeles, CA, USA

Aims: To demonstrate the feasibility and safety of percutaneous delivery of the novel inflow cannula of the CircuLite® SYNERGY®

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

cardiovascular interventionsheart diseasesleft ventricular assist devicepercutaneous treatment
Read next article
Percutaneous pulmonary artery denervation completely abolishes experimental pulmonary arterial hypertension in vivo

Latest news